These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 9022490)
1. Do neuroleptic drugs hasten cognitive decline in dementia? Prospective study with necropsy follow up. McShane R; Keene J; Gedling K; Fairburn C; Jacoby R; Hope T BMJ; 1997 Jan; 314(7076):266-70. PubMed ID: 9022490 [TBL] [Abstract][Full Text] [Related]
2. Neuroleptic sensitivity in patients with senile dementia of Lewy body type. McKeith I; Fairbairn A; Perry R; Thompson P; Perry E BMJ; 1992 Sep; 305(6855):673-8. PubMed ID: 1356550 [TBL] [Abstract][Full Text] [Related]
3. Do neuroleptic drugs hasten cognitive decline in dementia? Trials must determine which neuroleptics are best in dementia. Tobiansky R; Blanchard M BMJ; 1997 May; 314(7091):1411; author reply 1412. PubMed ID: 9161322 [No Abstract] [Full Text] [Related]
4. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia. Declercq T; Petrovic M; Azermai M; Vander Stichele R; De Sutter AI; van Driel ML; Christiaens T Cochrane Database Syst Rev; 2013 Mar; (3):CD007726. PubMed ID: 23543555 [TBL] [Abstract][Full Text] [Related]
5. Do neuroleptic drugs hasten cognitive decline in dementia? Carriers of apolipoprotein E epsilon 4 allele seem particularly susceptible to their effects. Holmes C; Fortenza O; Powell J; Lovestone S BMJ; 1997 May; 314(7091):1411; author reply 1412. PubMed ID: 9161321 [No Abstract] [Full Text] [Related]
6. Do neuroleptic drugs hasten cognitive decline in dementia? Authors have not proved their argument. Bentham PW; Goh SE; Gregg EM; Madeley P; Patel AR; Taylor AP BMJ; 1997 May; 314(7091):1412. PubMed ID: 9161323 [No Abstract] [Full Text] [Related]
8. Neuroleptics are associated with more severe tangle pathology in dementia with Lewy bodies. Ballard CG; Perry RH; McKeith IG; Perry EK Int J Geriatr Psychiatry; 2005 Sep; 20(9):872-5. PubMed ID: 16116579 [TBL] [Abstract][Full Text] [Related]
9. Trajectories of cognitive decline in different types of dementia. Smits LL; van Harten AC; Pijnenburg YA; Koedam EL; Bouwman FH; Sistermans N; Reuling IE; Prins ND; Lemstra AW; Scheltens P; van der Flier WM Psychol Med; 2015 Apr; 45(5):1051-9. PubMed ID: 25229325 [TBL] [Abstract][Full Text] [Related]
11. Delaying cognitive and physical decline through multidomain interventions for residents with mild-to-moderate dementia in dementia care units in Taiwan: A prospective cohort study. Liang CK; Chou MY; Chen LY; Wang KY; Lin SY; Chen LK; Lin YT; Liu TY; Loh CH Geriatr Gerontol Int; 2017 Apr; 17 Suppl 1():36-43. PubMed ID: 28436184 [TBL] [Abstract][Full Text] [Related]
12. Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia. Soares-Weiser K; Rathbone J Cochrane Database Syst Rev; 2006 Jan; (1):CD000459. PubMed ID: 16437425 [TBL] [Abstract][Full Text] [Related]
13. Fifteen-year follow-up of 92 hospitalized adults with Down's syndrome: incidence of cognitive decline, its relationship to age and neuropathology. Margallo-Lana ML; Moore PB; Kay DW; Perry RH; Reid BE; Berney TP; Tyrer SP J Intellect Disabil Res; 2007 Jun; 51(Pt. 6):463-77. PubMed ID: 17493029 [TBL] [Abstract][Full Text] [Related]
15. Association of Cerebral Microbleeds With Cognitive Decline and Dementia. Akoudad S; Wolters FJ; Viswanathan A; de Bruijn RF; van der Lugt A; Hofman A; Koudstaal PJ; Ikram MA; Vernooij MW JAMA Neurol; 2016 Aug; 73(8):934-43. PubMed ID: 27271785 [TBL] [Abstract][Full Text] [Related]
16. Cerebral white matter changes and rate of progression of dementia during cholinesterase inhibitor treatment: a retrospective cohort study. Devine ME; Fonseca JA; Walker RW; Sikdar T; Stevens T; Walker Z Int J Geriatr Psychiatry; 2007 Nov; 22(11):1120-6. PubMed ID: 17457951 [TBL] [Abstract][Full Text] [Related]
17. Behaviour changes in dementia. 1: Point of entry data of a prospective study. Hope T; Keene J; Gedling K; Cooper S; Fairburn C; Jacoby R Int J Geriatr Psychiatry; 1997 Nov; 12(11):1062-73. PubMed ID: 9427090 [TBL] [Abstract][Full Text] [Related]
18. [Effectiveness of typical and atypical neuroleptics in the control of behavioral and psychopathological symptoms of dementia. Results of a retrospective study]. Martin Carrasco M; Ballesteros J; Bulbena A; Baraibar G; García C; Minguez L; Blanco J; de Blas J; Agüero JA; Ibarra N Actas Esp Psiquiatr; 2006; 34(4):251-6. PubMed ID: 16823686 [TBL] [Abstract][Full Text] [Related]
19. Delirium is a risk factor for further cognitive decline in cognitively impaired hip fracture patients. Krogseth M; Watne LO; Juliebø V; Skovlund E; Engedal K; Frihagen F; Wyller TB Arch Gerontol Geriatr; 2016; 64():38-44. PubMed ID: 26952375 [TBL] [Abstract][Full Text] [Related]
20. [Neuroleptics in psychogeriatrics. Evaluation of a treatment proposal]. Willekens-Bogaers MA; Smits GW Tijdschr Gerontol Geriatr; 1990 Jul; 21(3):99-107. PubMed ID: 1974367 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]